Address
Email address
Phone number
https://genecode.comGenecode - Reversing Neurodegeneration - Restoring Life.Defeating neurodegenerative diseases by developing systemically, available, safe and effective medicines, building on a deep understanding of neurodegeneration and regeneration of the nervous system.
Name
GeneCode AS
Registry code
10362550
VAT number
EE101059031
Type
AS - Joint Stock Company
Status
Registered
Foundation date
15.01.1998 (28)
Financial year
01.01-31.12
Capital
75 600.00 €
Activity
72111 - Research and experimental development on biotechnology
-
508 690 €
-
3 251 €
(estimate is approximate)
5 323 649 €
3
Submitted
No tax arrears
10%
8%
| Owner | Representative | Beneficial owner | |
|---|---|---|---|
| Mart Saarma
| - | - | Member of a higher management body, i.e. board member or supervisory board member |
| Thomas Björn Waldin
| - | - | Direct ownership |
| Paavo Pilv
| - | Board member | - |
| AnsonBaer Nordic OÜ 11365489 | 40% - 30 240.00 EUR | - | - |
| MPPS Investeeringud OÜ 10634869 | 25% - 18 900.00 EUR | - | - |
| Owner | Representative | Beneficial owner |
|---|
| 2019 10.11.2020 | 2020 03.09.2021 | 2021 06.06.2022 | 2022 20.06.2023 | 2023 05.04.2024 | 2024 06.10.2025 | |
|---|---|---|---|---|---|---|
| Total Revenue | - | 4 250 € | 0 € | - | - | - |
| Net profit (loss) for the period | -28 481 € | -26 692 € | -69 880 € | 1 262 642 € | 951 155 € | 508 690 € |
| Profit Margin | - | -628% | - | - | - | - |
| Current Assets | 5 502 € | 4 851 € | 20 240 € | 509 297 € | 848 038 € | 278 026 € |
| Fixed Assets | 2 672 921 € | 2 685 528 € | 2 626 763 € | 3 789 940 € | 5 171 290 € | 5 998 560 € |
| Total Assets | 2 678 423 € | 2 690 379 € | 2 647 003 € | 4 299 237 € | 6 019 328 € | 6 276 586 € |
| Current Liabilities | 31 892 € | 2 797 € | 45 840 € | 228 926 € | 945 857 € | 590 269 € |
| Non Current Liabilities | 1 041 236 € | 1 108 979 € | 0 € | 206 506 € | 258 512 € | 362 668 € |
| Total Liabilities | 1 073 128 € | 1 111 776 € | - | 435 432 € | 1 204 369 € | 952 937 € |
| Share Capital | 37 800 € | 37 800 € | 75 600 € | 75 600 € | 75 600 € | 75 600 € |
| Equity | 1 605 295 € | 1 578 603 € | 2 601 163 € | 3 863 805 € | 4 814 959 € | 5 323 649 € |
| Employees | 0 | 0 | 0 | 3 | 3 | 3 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2025 Q4 | 118 580 € | 15 131 € | 18 236 € | 3 |
| 2025 Q3 | 182 550 € | 19 680 € | 21 645 € | 3 |
| 2025 Q2 | 189 346 € | 8 245 € | 10 123 € | 3 |
| 2025 Q1 | 321 410 € | 9 843 € | 19 811 € | 3 |
| 2024 Q4 | 95 338 € | 16 938 € | 19 148 € | 3 |
| 2024 Q3 | 142 219 € | 7 875 € | 15 908 € | 3 |
| 2024 Q2 | 77 325 € | 4 343 € | 9 428 € | 2 |
| 2024 Q1 | 67 839 € | 0 € | 10 422 € | 2 |
| 2023 Q4 | 19 867 € | 8 807 € | 11 948 € | 3 |
| 2023 Q3 | 102 960 € | 9 884 € | 12 073 € | 3 |
| 2023 Q2 | 223 918 € | 8 723 € | 11 948 € | 3 |
| 2023 Q1 | 589 044 € | 10 694 € | 11 842 € | 3 |
| 2022 Q4 | 267 048 € | 0 € | 10 881 € | 3 |
| 2022 Q3 | 257 587 € | 9 153 € | 12 302 € | 3 |
| 2022 Q2 | 701 877 € | 0 € | 5 847 € | 3 |
| 2022 Q1 | 4 604 € | 1 663 € | 5 462 € | 3 |
